Jump to content

Dihydroceramide desaturase

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 13:07, 7 March 2016 (top: Journal cites: fix journal name, using AWB (11965)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Dihydroceramide desaturase
Identifiers
EC no.3.4.24.81
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Search
PMCarticles
PubMedarticles
NCBIproteins

Dihydroceramide desaturase is the enzyme involved in the conversion of dihydroceramide into ceramide by inserting the 4,5-trans-double bond to the sphingolipid backbone of dihydroceramide. DDase require the O2 and the NAD(P)H as cofactor.[1]

The activity of DDase is influenced by several factors as 1.alkyl chain length of the sphingoid base (in the order C18 > C12 > C8) and fatty acid (C8 > C18)2. The stereochemistry of the sphingoid base (D-erythro- > L-threo-dihydroceramides)3.the nature of the headgroup, with the highest activity with dihydroceramide, but some (approximately 20%) activity with dihydroglucosylceramide 4. The ability to utilize alternative reductants like ascorbic acid could substitute for a reduced pyridine nucleotide, but it act as inhibitory at higher concentrations.

N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11), is the inhibitor DDase activity.[2]

References

  1. ^ Rahmaniyan, Mehrdad; Curley, Robert W., Jr.; Obeid, Lina M.; Hannun, Yusuf A.; Kraveka, Jacqueline M. (13 April 2011). "Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for Fenretinide". J. Biol. Chem. 286 (28): 24754–64. doi:10.1074/jbc.M111.250779. PMID 21543327.{{cite journal}}: CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  2. ^ "Specificity of the Dihydroceramide Desaturase Inhibitor N-[(1R,2S)-2-Hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11) in Primary Cultured Cerebellar Neurons". Mol Pharmacol. 66 (6): 1671–8. Dec 2004. doi:10.1124/mol.104.003681. PMID 15371559.